US Patent 10889610 Alpha-D-galactoside inhibitors of galectins
Patent 10889610 was granted and assigned to Galecto Biotech on January, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+451 characters)
Article
Patent abstract
The present invention relates to a compound of the general formula (1). The compound of formula (1) is suitable for use in a method for treating a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human. Furthermore, the present invention concerns a method for treatment of a disorder relating to the binding of a galectin, such as galectin-3 to a ligand in a mammal, such as a human.
Edits on 9 Oct, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Fredrik Zetterberg0
Hakon Leffler0
Ulf Nilsson0
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 31 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 25 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 6 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Feb, 2022
Golden AI
Edits made to:
Infobox (+11 properties)
US Patent 10889610 Alpha-D-galactoside inhibitors of galectins
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10889610
Date of patent
January 12, 2021
Patent application number
16313628
Date Filed
July 9, 2017
Patent citations
Patent primary examiner
Find more entities like US Patent 10889610 Alpha-D-galactoside inhibitors of galectins
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.